Vertex Pharmaceuticals (VRTX)
Add to Watchlists Create an Alert
78.29
-0.14 -0.18%
NASDAQ
May 23, 4:58PM
BATS Real time
Currency in USD
Vertex Pharmaceuticals Return on Assets:
-19.76% for March 31, 2013Vertex Pharmaceuticals Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -19.76% |
| Dec. 31, 2012 | -4.24% |
| Sept. 30, 2012 | 5.34% |
| June 30, 2012 | 18.46% |
| March 31, 2012 | 14.95% |
| Dec. 31, 2011 | 1.59% |
| Sept. 30, 2011 | -17.18% |
| June 30, 2011 | -43.15% |
| March 31, 2011 | -44.62% |
| Dec. 31, 2010 | -41.95% |
| Sept. 30, 2010 | -41.44% |
| June 30, 2010 | -40.12% |
| March 31, 2010 | -38.82% |
| Dec. 31, 2009 | -42.73% |
| Sept. 30, 2009 | -47.22% |
| June 30, 2009 | -50.32% |
| March 31, 2009 | -48.08% |
| Dec. 31, 2008 | -50.98% |
| Sept. 30, 2008 | -48.19% |
| June 30, 2008 | -49.03% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
VRTX Return on Assets Benchmarks
| Companies | |
|---|---|
| Cleveland BioLabs | -66.57% |
| Gilead Sciences | 13.69% |
| Merck | 5.83% |
VRTX Return on Assets Rankings
| Overall |
46th percentile 4244 of 8006 |
| Sector |
53rd percentile 319 of 686 in Healthcare |
| Industry |
75th percentile 60 of 248 in Biotechnology |
VRTX Return on Assets Range, Past 5 Years
| Minimum | -50.98% | Dec 2008 |
| Maximum | 18.46% | Jun 2012 |
| Average | -29.37% |